Companies related to Antibody-Drug Conjugates

Science revives

Where Empathy Meets Science to Accelerate Life Sciences Research

Biotech Consultancy Supporting Biopharmaceutical Development Globally

We develop breakthrough treatments for Claudin1-positive tumors and organ fibrosis

Putting science to work

BRINGING YOUR SCIENCE TO LIFE

MANAGING CYANOBACTERIA

Passion for Innovation. Compassion for Patients.

Passion for Innovation. Compassion for Patients.

Your CDMO Partner for On-Time Process Development and cGMP Manufacturing.

RABCancer: A Predictive Platform for Antibody-Drug Conjugates. Follow us for insights into ADC trafficking & biomarkers

Creating class-leading ADCs with enhanced tumor specificity

Making way for breakthroughs

Securing Life Sciences Supply Chain - Customized conjugation & formulation solutions. celares is now part of Biosynth.

Integrated Chemistry Solution Provider

Building tomorrow's antibody-drug conjugates (ADCs)

Our mission is to discover and develop life-changing antibody-drug conjugates (ADCs) for patients fighting cancer.

We target the cells that drive fibrosis

Reimagining ADCs.